http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2705952-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5da9ef6c28994f379e69b07babaad8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2008-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_323df367236ba0acf07d04ff56344d8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce57ba2ad80fdc6e2c6c59fa393d6f3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cde675c0850e8d4b9a70cf3d73855d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd74820fb38ff588ba1c25bc8da56f8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8534c30140ca113395780c16e94d0320 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1291c289cdddb3f9a80f5a56962b374 |
| publicationDate | 2009-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2705952-A1 |
| titleOfInvention | Methods for detecting lung cancer and monitoring treatment response |
| abstract | A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment with curative intent is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with the a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described. |
| priorityDate | 2007-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.